for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Novartis raises full year outlook

July 17 - Swiss drug maker Novartis raises its full year outlook as a generic competitor to its blockbuster blood pressure pill Diovan is delayed. Hayley Platt reports.

最新のビデオ
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up